Chum salmon, who dated the river, was born again with medicine and cosmetics. When she cut the belly of a woman who died, 2500 red eggs poured out. Semen squeezed from the male's genitals was scattered over it. The Chum salmon artificial insemination work was in full swing at the Korea Fisheries Resources Management Corporation's Inland Water Life Resource Center in Gangwon Province and South Korea Yang Yang, which was visited on the 25th of last month.
When I went to the Yang Chang Chum salmon office, the Pacific Chum salmon, which swims 20,000 kilometers (km) and returns to the stream in its hometown, dies of energy after spawning. It is because they stopped feeding at the same time as returning and yielded both nutrients to eggs and sperm.
Even if you die, the success rate of natural fertilization is only 10 to 15%. When artificial fertilization is done, the hatching rate rises to 85%. Unlike Japan and Russia, artificial insemination is not an option but a necessity in Korea, a "Chum salmon tribal country." Chum salmon, who is about to die with all his strength, is the target.
10,000 Chum salmon, with Gangwon Province and South Korea streams, returns to the Namdae Stream, Myeongpa Stream, Bukcheon and Yeongok Stream in October and November every year. The Chum salmon office in Namdaecheon has created a terraced waterway using the habit of climbing back to Chum salmon. The first thing that happens is that the Chum salmon, which is upside down, is gathered at the office when the rapids are spilled from the office.
The male Chum salmon Semen, which remains after the force artificial insemination of Chum salmon, which goes upside down the river, becomes a raw material for medicines and cosmetics. Chum salmon, which has human-like DNA, has a metabolic activity substance called PDRN in reproductive cells. PDRN is a substance with anti-inflammatory and tissue regeneration effects. It is mainly used for cosmetic products such as wound treatment, tissue regeneration, joint and muscle regeneration injection, regeneration cream and ampoule and filler after skin transplantation.
Cheum salmon genital epididymis (regenerative organs) are also the main raw materials for them, and PNs with larger molecular weight (longer DNA length) are extracted from testis than PDRNs. PDRN is mainly used for medicines, cosmetics, and health functional foods, and PN is mainly used for medical devices.
Parma Research and KoreaBMI are the two markets that are divided into two markets: the industry estimates the PDRN injection market at between 18 billion and 20 billion won a year.
Meanwhile, the Patent Court ruled in January this year that Mastelly's PDRN patent was invalid. The patent lawsuit between Parma Research and KoreaBMI, which won the technology from Mastelli, is currently under way.
“[Hyundai Department Store News] Hydendai Department Store Vaio Enterprise BridgeVaio Therapeutics IPO
BridgeVaio Therapeutics, a Hyundai Department Store Vaio company that exported new drug candidates for idiopathic pulmonary fibrosis (IPF) treatment to Boehringer Ingelheim in July, is expected to enter the KOSDAQ market this year. A total of 700,000 shares will be contested, and the public band will be between 70,000 and 80,000 won, and the planned amount will be between 49 billion and 56 billion won. The company will confirm the public offering price after demand forecasts from December 9 to 10, and receive a subscription for public offerings from December 12 to 13. The industry sees the value of the company at about 400 billion won.”